Categories


New, contradictory evidence from Xarelto makers could lead to retrial for plaintiff

September 21, 2017 - There is an effective lab test to protect patients taking Xarelto, but that isn’t what jurors heard during last month’s trial against Johnson & Johnson’s Janssen Pharmaceuticals and... Read More


Third Xarelto Trial Begins This Week

August 9, 2017 - Last month, U.S. District Judge Eldon E. Fallon rejected the latest attempts by Xarelto makers to dodge consumers’ efforts to hold them accountable. Judge Fallon denied the defendants’... Read More


Second Xarelto bellwether trial underway

May 25, 2017 - The second bellwether trial involving bleeding risks with the blood thinner Xarelto is slated to begin Tuesday following the Memorial Day holiday. Read More


First Xarelto trial set for April; blood thinner linked to severe bleeding risk

February 24, 2017 - The first of four bellwether trials for the Xarelto multidistrict litigation (MDL) is set to begin on April 24, 2017 in the Eastern District of Louisiana. Read More


New lawsuit targets bleeding risks with Xarelto blood thinnner

March 25, 2015 - Twelve people treated with Xarelto blood thinner have filed a lawsuit in California federal court claiming that they were not sufficiently warned that the drug could cause them to bleed... Read More


Beasley Allen lawyer Andy Birchfield appointed to leadership role in Xarelto blood thinner multidistrict litigation

February 10, 2015 - Beasley Allen Mass Torts section head Andy Birchfield has been appointed as Co-Lead Counsel for the Plaintiffs Steering Committee (PSC) in multidistrict litigation (MDL) over blood-thinner... Read More


Xarelto blood thinner lawsuits consolidated in Louisiana federal court; drug linked to serious bleeding risk

December 15, 2014 - Nearly two dozen lawsuits filed against Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Corp. over the blood thinner Xarelto have been consolidated in Louisiana federal... Read More


back to top